EDA fibronectin is necessary for myofibroblast differentiation15 and its absence results in wound healing or pulmonary fibrosis reduction67, suggesting that EDA fibronectin could be addressed as a therapeutic target. This evidence concerns the gene FN1 and pulmonary fibrosis.